Periodontal Disease Articles & Analysis
11 news found
VAX-PG: Vaxcyte expects to nominate a final vaccine candidate for VAX-PG, its novel therapeutic vaccine designed to treat periodontal disease, by the end of 2022. First Quarter 2022 Financial Results Cash Position: Cash, cash equivalents and investments were $352.3 million as of March 31, 2022, compared to $273.1 million as of December 31, 2021. ...
(Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 9, 2022 at 8:30 a.m. ...
(Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in and host one-on-one meetings at the following investor conferences: BofA Securities 2022 Healthcare Conference May 10-13, 2022; Las Vegas, NV Fireside chat ...
(Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 12:45 p.m. ...
The study is being conducted at approximately 13 sites in the United States. About Pneumococcal Disease Pneumococcal disease (PD) is an infection caused by Streptococcus pneumoniae (pneumococcus) bacteria. ...
The study will be conducted at approximately 13 sites in the United States. About Pneumococcal Disease Pneumococcal disease (PD) is an infection caused by Streptococcus pneumoniae (pneumococcus) bacteria. ...
(Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today that it has commenced an underwritten public offering of its common stock and pre-funded warrants. ...
Antibiotics are used to treat pneumococcal disease, but some strains of the bacteria have developed resistance to treatments. ...
"Many dogs, especially toy dog breeds, are predisposed to periodontal disease," said Steve Eby, Business Development Director at RevBio. ...
(Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will present at the 11th Annual SVB Leerink Global Healthcare Conference on Friday, February 18, 2022 at 2:20 p.m. ...
It is vital for people throughout the world to continue to have access to a safe, durable, affordable treatment for tooth decay.The ADA is also delighted that the proposed treaty recognizes the need for national programs to prevent oral disease and calls for more research into developing new treatment options.Long term, it is critically important to raise global awareness of the ...